NMIMC
ALXN

Northwestern Mutual Investment Management Company’s Alexion Pharmaceuticals ALXN Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,037
Closed -$1.84M – 914
2021
Q2 		$1.84M Buy
10,037
+71
+0.7% +$12.2K 0.03% 225
2021
Q1 		$1.52M Sell
9,966
-2,043
-17% -$316K 0.03% 278
2020
Q4 		$1.88M Sell
12,009
-122
-1% -$15.7K 0.02% 344
2020
Q3 		$1.36M Hold
12,131
– – 0.02% 399
2020
Q2 		$1.36M Buy
12,131
+609
+5% +$64.7K 0.02% 400
2020
Q1 		$1.03M Buy
11,522
+2,926
+34% +$287K 0.02% 421
2019
Q4 		$930K Buy
8,596
+57
+0.7% +$6.1K 0.02% 536
2019
Q3 		$836K Buy
8,539
+33
+0.4% +$3.72K 0.02% 556
2019
Q2 		$1.11M Sell
8,506
-25,450
-75% -$3.28M 0.03% 424
2019
Q1 		$4.59M Buy
33,956
+344
+1% +$42.8K 0.08% 204
2018
Q4 		$3.27M Sell
33,612
-5,387
-14% -$637K 0.05% 241
2018
Q3 		$5.42M Sell
38,999
-3,609
-8% -$453K 0.08% 207
2018
Q2 		$5.29M Buy
42,608
+2,258
+6% +$264K 0.08% 219
2018
Q1 		$4.5M Sell
40,350
-10,113
-20% -$1.21M 0.07% 236
2017
Q4 		$6.04M Buy
50,463
+425
+0.8% +$51.8K 0.1% 200
2017
Q3 		$7.02M Sell
50,038
-1,491
-3% -$203K 0.12% 172
2017
Q2 		$6.27M Buy
51,529
+6,124
+13% +$713K 0.11% 187
2017
Q1 		$5.5M Buy
45,405
+19,655
+76% +$2.53M 0.1% 183
2016
Q4 		$3.15M Buy
25,750
+3,564
+16% +$436K 0.06% 189
2016
Q3 		$2.72M Buy
22,186
+13,638
+160% +$1.76M 0.06% 184
2016
Q2 		$998K Sell
8,548
-53
-0.6% -$7.52K 0.02% 284
2016
Q1 		$1.2M Buy
8,601
+41
+0.5% +$6.02K 0.03% 250
2015
Q4 		$1.63M Buy
8,560
+274
+3% +$47.9K 0.03% 257
2015
Q3 		$1.3M Buy
8,286
+814
+11% +$148K 0.03% 308
2015
Q2 		$1.35M Buy
7,472
+142
+2% +$24.5K 0.03% 337
2015
Q1 		$1.27M Buy
+7,330
New +$1.33M 0.03% 359

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Northwestern Mutual Investment Management Company's ALXN Position: Q3 2021 in Review

Northwestern Mutual Investment Management Company sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 10,037 shares — an estimated $1.84M sold.

Northwestern Mutual Investment Management Company first reported a position in ALXN in Q1 2015 and held it in 26 quarters. The position peaked at $7.02M in Q3 2017. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Northwestern Mutual Investment Management Company reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Northwestern Mutual Investment Management Company sold 10,037 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.84M.
  • Northwestern Mutual Investment Management Company first reported a position in Alexion Pharmaceuticals in Q1 2015 and held it in 26 quarters.
  • Northwestern Mutual Investment Management Company's Alexion Pharmaceuticals position peaked at $7.02M in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q3 2021, filed 15 Nov 2021.